Literature DB >> 3275485

5-Fluorouracil-associated cardiotoxicity.

N J Freeman1, M E Costanza.   

Abstract

Cardiotoxicity manifested as myocardial ischemia is not generally recognized as a side effect of 5-fluorouracil. However, there have been at least 35 cases reported since 1975. In only one of these cases was a somewhat detailed evaluation done to rule out underlying coronary disease. The case reported here of 5-FU cardiotoxicity included an extensive cardiac evaluation to rule out underlying coronary disease and to assess spasm. The literature on 5-FU cardiotoxicity is also reviewed, and its possible mechanisms are analyzed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3275485     DOI: 10.1002/1097-0142(19880101)61:1<36::aid-cncr2820610108>3.0.co;2-6

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  30 in total

1.  Simultaneous neoadjuvant radiochemotherapy with capecitabine and oxaliplatin for locally advanced rectal cancer. Treatment outcome outside clinical trials.

Authors:  J Winkler; L Zipp; J Knoblich; F Zimmermann
Journal:  Strahlenther Onkol       Date:  2012-03-10       Impact factor: 3.621

2.  5-fluorouracil in the treatment of scleroderma: a randomised, double blind, placebo controlled international collaborative study.

Authors:  J A Casas; P A Saway; I Villarreal; C Nolte; B L Menajovsky; E E Escudero; W D Blackburn; G S Alarcón; C P Subauste
Journal:  Ann Rheum Dis       Date:  1990-11       Impact factor: 19.103

3.  Severe 5-fluorouracil toxicity caused by reduced dihydropyrimidine dehydrogenase activity due to heterozygosity for a G-->A point mutation.

Authors:  A B van Kuilenburg; P Vreken; L V Beex; R A De Abreu; A H van Gennip
Journal:  J Inherit Metab Dis       Date:  1998-06       Impact factor: 4.982

Review 4.  Ischemic Heart Disease: Special Considerations in Cardio-Oncology.

Authors:  Dana Elena Giza; Fernando Boccalandro; Juan Lopez-Mattei; Gloria Iliescu; Kaveh Karimzad; Peter Kim; Cezar Iliescu
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-05

5.  5-fluorouracil induced pericarditis.

Authors:  Ammar Killu; Malini Madhavan; Kavita Prasad; Abhiram Prasad
Journal:  BMJ Case Rep       Date:  2011-04-15

6.  Comparison of 5-fluorouracil anabolite levels after intravenous bolus and continuous infusion.

Authors:  T A Stein; B Bailey; G P Burns
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

7.  Capecitabine-induced cardiotoxicity: case report and review of the literature.

Authors:  C Ang; M Kornbluth; M P Thirlwell; R D Rajan
Journal:  Curr Oncol       Date:  2010-02       Impact factor: 3.677

8.  Reversible cardiogenic shock following 5-fluorouracil infusion.

Authors:  Charles Ferté; Carlos Gomez Roca; Yohann Loriot; Rastislav Bahleda; Cristian Moldovan; Ariel Cohen; Hassan Izzedine; Jean-Charles Soria; Stephane Ederhy
Journal:  Invest New Drugs       Date:  2009-06-05       Impact factor: 3.850

9.  Combined haemoperfusion, haemofiltration and haemodialysis for systemic detoxification in locoregional 5-fluorouracil therapy.

Authors:  F Keller; U Gallkowski; W Roth; J Boese-Landgraf
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

Review 10.  Cardiovascular Toxicity of Molecular Targeted Therapy in Cancer Patients: A Double-Edged Sword.

Authors:  Kuan-Liang Liu; Jen-Shi Chen; Shin-Cheh Chen; Pao-Hsien Chu
Journal:  Acta Cardiol Sin       Date:  2013-07       Impact factor: 2.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.